School of Medicine


Showing 1-20 of 65 Results

  • Andrei Iagaru

    Andrei Iagaru

    Associate Professor of Radiology (Nuclear Medicine) at the Stanford University Medical Center

    Current Research and Scholarly InterestsCurrent research projects include:
    1) PET/MRI and PET/CT for Early Cancer Detection
    2) Targeted Radionuclide Therapy
    3) Clinical Translation of Novel PET Radiopharmaceuticals;

  • David Iberri, MD

    David Iberri, MD

    Clinical Assistant Professor, Medicine - Hematology

    BioDr. Iberri is a medical oncologist and hematologist who specializes in the treatment of hematologic malignancies. His clinical practices runs the gamut of malignant and non-malignant hematologic disorders including acute and chronic leukemias, multiple myeloma and lymphomas, and bleeding and thrombotic disorders. He is actively involved in clinical trials evaluating novel agents in hematologic malignancies. His research interests are in the development and application of biomarkers to select patients most likely to benefit from therapy.

  • Ibrahim A. Idakoji MD, MPH

    Ibrahim A. Idakoji MD, MPH

    Clinical Assistant Professor, Radiology

    BioIbrahim Idakoji is a native of the Bay Area and practicing Interventional Radiologist at Stanford Medical Center who specializes in minimally invasive, image-guided percutaneous and endovascular procedures that aid in the diagnosis and treatment of complex vascular and oncologic disease. Some of his areas of interest include: treatment of both acute and chronic venous thromboembolic disease, treatment of primary and metastatic hepatic malignancy, and percutaneous pain management.

  • Juliana Idoyaga

    Juliana Idoyaga

    Assistant Professor of Microbiology and Immunology

    Current Research and Scholarly InterestsThe Idoyaga Lab is focused on the function and biology of dendritic cells, which are specialized antigen-presenting cells that initiate and modulate our body’s immune responses. Considering their importance in orchestrating the quality and quantity of immune responses, dendritic cells are an indisputable target for vaccines and therapies.

    Dendritic cells are not one cell type, but a network of cells comprised of many subsets or subpopulations with distinct developmental pathways and tissue localization. It is becoming apparent that each dendritic cell subset is different in its capacity to induce and modulate specific types of immune responses; however, there is still a lack of resolution and deep understanding of dendritic cell subset functional specialization. This gap in knowledge is an impediment for the rational design of immune interventions. Our research program focuses on advancing our understanding of mouse and human dendritic cell subsets, revealing their endowed capacity to induce distinct types of immune responses, and designing novel strategies to exploit them for vaccines and therapies.

  • Debra M. Ikeda, M.D., FACR, FSBI

    Debra M. Ikeda, M.D., FACR, FSBI

    Professor of Radiology (Breast Imaging)

    Current Research and Scholarly InterestsMy research interests are quality improvement in mammography positioning, digital breast tomosynthesis (DBT) cancer detection and imaging pitfalls, MRI-guided breast biopsy, MRI BIRADS 3 lesions, fiducial markers for Radiation Therapy, correlation of breast cancer and FDG PET imaging, percutaneous breast biopsy

  • Gentaro Ikeda

    Gentaro Ikeda

    Postdoctoral Research Fellow, Cardiovascular Medicine

    BioMy long-term goal is to become a physician scientist and develop innovative diagnostic and therapeutic modalities for patients with cardiovascular disease. Based on my experience as a cardiologist for the past 5 years, I have become aware of major clinical shortcomings, specifically in the current pharmaceutical therapies for myocardial infarction (MI) and chronic heart failure (HF). Some evidence-based drug therapies, including β-blockers, ivabradine, and renin–angiotensin–aldosterone antagonists are difficult to apply to critical patients due to adverse side effects. Drugs that have shown efficacy in basic animal experiments have failed to show significant benefits in clinical trials. To address these problems, I moved to academia to conduct translational research. During my graduate training in the Egashira Lab, I focused on drug delivery systems (DDS) that target mitochondria in animal models of MI. I obtained advanced skills in molecular biology, mitochondrial bioenergetics, and animal surgery. I realized the importance of translational research and the great potential of DDS to overcome many clinical problems. I developed nanoparticle-mediated DDS containing cyclosporine for the treatment of patients with MI. I published a first author paper and received academic awards for my novel science. Since becoming a postdoctoral fellow in the Yang Lab, I have continued to build upon my previous training in translational research. I am currently developing an innovative therapy, namely, extracellular vesicles-mediated mitochondrial transfer for the failing heart.

  • Fumiaki Ikeno

    Fumiaki Ikeno

    Program Director (U.S) Japan Biodesign, Stanford Biodesign, Medicine - Med/Cardiovascular Medicine

    BioProgram Director (U.S) Japan Biodesign, Stanford Biodesign
    Cardiovascular Medicine, Stanford University


    Dr. Ikeno is a Research Associate, Cardiovascular Medicine, Stanford University. In this role, he is responsible for pre clinical studies including GLP for medical devices and also regenerative medicines for cardiovascular diseases. Currently, he is devoting himself to the international regulatory project between Japan and the United States, also known as "Harmonization by Doing", whose focus is to collaborate with regulatory agencies such as FDA, PMDA/MHLW, academia and industries for improving the regulatory process in the 2 largest medtech markets. Dr. Ikeno also devoted himself to found Japan biodesign program which is a collaborative program with University of Tokyo, Osaka University, Tohoku University, Japan Federation Medical Device Association, Ministry of Education Japan and Stanford biodesign program. Currently, Dr. Ikeno serves as the Program Director (US) for Japan Biodesign. Dr. Ikeno is co-founder and board member of US-Japan MedTech Frontier which is a non-profit cooperate to make a trans-pacific eco-system of medical device between Japan and USA.

    After 9 years clinical practice as an interventional cardiologist and Family Doctor in rural areas of Japan, Dr. Ikeno came to Stanford as a Researcher and completed his Biodesign Certificate Program. Being part of the ecosystem in Silicon Valley, Dr. Ikeno participated in more than 200 medtech projects and 50 GLP studies as well as in the analysis of clinical trials for cardiovascular medicine (BARI2D, FAME, ReOPEN etc). His other academic consortium projects include Peripheral Academic Research Consortium, Global Consensus Working Group of Optical Coherence Tomography, and Japan-US consensus document for the treatment of critical limb ischemia.

    Over the last decade, Dr. Ikeno has served as an advisor for medical device industries and currently serves as a chief medical officer of an incubation fund specific for medtech (Medventure Partners, Inc, Tokyo) as a spin-off from Innovation Network Corporation of Japan (INCJ) that is the largest government and private partnership fund in Japan. He is also serving as a chair of cardiovascular working group of APAN (Asian Pacific Advanced Network) that contributes the remote education, research activities, and tele-health using a specialized internet network. Dr.Ikeno is also serving as consulting faculty/lecturer roles in several universities in Japan including University of Tokyo, Osaka University, Tsukuba University etc. Dr. Ikeno has authored over 70 peer reviewed publications and textbooks and has been invited to lecture at international medical conferences. Dr. Ikeno is a council member of U.S.- Japan Council which is a non-profit organization by Japanese American. He is serving as a mentor for START-X MED which is an accelerating program for Stanford related entrepreneurs in medical fields.

    Contact Information


    Falk CVRC CV007
    300 Pasteur Drive
    Palo Alto, CA 94305-5406

  • Asaf Ilovitsh

    Asaf Ilovitsh

    Postdoctoral Research Fellow, Molecular Imaging Program at Stanford

    BioAsaf Ilovitsh received his B.Sc. in Physics (2004), M.Sc. in Electrical Engineering (2012), and Ph.D. in Electrical Engineering (2016), from Bar Ilan University, Israel. His Ph.D. research involved developing new methods for super resolution optical imaging, especially using the time domain. Asaf joined the Ferrara lab in 2016 as a postdoctoral fellow. His research involves developing rapid elastography measurements using MR-guided Focused Ultrasound (MRgFUS), and developing new ultrasound imaging methods.

  • Tali Ilovitsh

    Tali Ilovitsh

    Postdoctoral Research Fellow, Molecular Imaging Program at Stanford

    BioTali Ilovitsh is a postdoctoral fellow in Prof. Katherine Ferrara laboratory at the Department of Radiology, School of Medicine, Stanford University. She received her B.Sc. (2010), M.Sc. in a direct track (2011), and Ph.D. (2016) degrees in electrical engineering from Bar Ilan University, Israel. Her Ph.D. research in the field of optical imaging was focused on the development of super-resolution techniques for microscopy. Since joining the Ferrara lab in 2016 she has been working in the fields of ultrasound therapy and imaging. Her research is focused on the development of medical ultrasound technologies that provide non-invasive, cost effective, real-time and safe monitoring, diagnostics and therapy for clinically relevant problems. Currently, she uses low frequency focused ultrasound as a mean to open the blood brain barrier and facilitate drug delivery. Additionally, she develops an ultrasound beam shaping technology that allows to image tissues beyond ultrasonically-impenetrable obstacles, and is also used for label-free ultrasound super-resolution.

  • Daniel Imler, MD

    Daniel Imler, MD

    Clinical Assistant Professor, Emergency Medicine
    Clinical Assistant Professor, Pediatrics

    Current Research and Scholarly InterestsI am interested in understanding the impact of smart, agile clinical pathways to drive behavior change among providers.